
    
      PRIMARY OBJECTIVES:

      I. To assess the safety and feasibility of combined single fraction high dose rate (HDR)
      brachytherapy followed immediately by interstitial hyperthermia treatment of radio-recurrent
      prostate cancer.

      SECONDARY OBJECTIVES:

      I. To assess long-term toxicity. II. To provide a preliminary assessment of efficacy. III. To
      obtain blood for future analysis of immune response to combined radiation therapy and
      hyperthermia.
    
  